SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-22-012619
Filing Date
2022-07-20
Accepted
2022-07-20 09:01:41
Documents
12
Period of Report
2022-07-20
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp177337_8k.htm   iXBRL 8-K 30791
  Complete submission text file 0000950103-22-012619.txt   205435

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bhc-20220720.xsd EX-101.SCH 3042
3 XBRL LABEL FILE bhc-20220720_lab.xml EX-101.LAB 34476
4 XBRL PRESENTATION FILE bhc-20220720_pre.xml EX-101.PRE 22602
6 EXTRACTED XBRL INSTANCE DOCUMENT dp177337_8k_htm.xml XML 3588
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 221092944
SIC: 2834 Pharmaceutical Preparations